Pfizer and BioNTech begin clinical trial for Omicron-specific vaccine
Pfizer and BioNTech have begun a clinical trial for their Omicron-specific Covid-19 vaccine candidate, they announced in a news release on Tuesday.
Stay updated with breaking news from Development Kathrin Jansen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer and BioNTech have begun a clinical trial for their Omicron-specific Covid-19 vaccine candidate, they announced in a news release on Tuesday.
The study will evaluate the vaccine for safety, tolerability and the level of immune response, as both a primary series and a booster dose.
CBS 58 is your local source for the Milwaukee news, Milwaukee weather, and Milwaukee sports.
Pfizer and BioNTech have begun a clinical trial for their Omicron-specific Covid-19 vaccine candidate, they announced in a news release on Tuesday.
Pfizer and BioNTech have begun a clinical trial for their Omicron-specific Covid-19 vaccine candidate, they announced in a news release on Tuesday.